AMP945
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMP945, covering 2025-02-05 to 2025-02-05. Get the full timeline:
Most recent: Clinical Trial Update: ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer [Phase 1, Phase 2]